Ignacio
Bernabeu Morón
Hospital Regional Universitario de Málaga
Málaga, EspañaPublicacións en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (7)
2024
-
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Endocrine-related cancer
-
Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion
European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466
-
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
Pituitary
-
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Endocrine-Related Cancer, Vol. 31, Núm. 7
2023
-
Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly
Clinical Endocrinology, Vol. 99, Núm. 4, pp. 378-385
2016
-
Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
Pituitary, Vol. 19, Núm. 2, pp. 127-137
2014
-
Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF
Endocrinology, Vol. 155, Núm. 11, pp. 4329-4340